The economic turmoil of the past couple years prompted countless job cuts in the pharmaceutical industry. Yet despite the reductions in work force, drug makers actually increased their investments in research and development in 2009, according to the newly released EU Industrial R&D Investment Scorecard, which analyzes the spending patterns of the top 1,400 companies around the world.

FierceBiotech crunched the numbers and came up with the top ten research spenders in pharma and biotech, respectively. Intriguingly, four of the top six pharma companies are based in the EU, while none of the top 10 biotechs are European. Meanwhile, Japanese companies — which saw a 26.5% hike in R&D investment last year, compared to just 2% in the US and EU — continue to climb the ranks.

The data, as assembled by FierceBiotech, follows below the jump:

BIG PHARMA

BIG BIOTECH